Press Review

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Business.punxsutawneyspirit

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
Chiemgau24 - Bayern

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Finanz Nachrichten

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Financial Content

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Bluefield Daily Telegraph

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Biotech 365

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
BioSpace

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Benzinga

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
The Pilot News

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
AP News

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Diversità nella scienza, parità di genere a Scienza e virgola
ANSA
Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
ANSA

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Yahoo! Finance

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
Via TT

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
The Valdosta Daily Times

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.

Read the article here.

L'intelligenza artificiale parla anche il reatino: «Non dobbiamo aver paura, può essere una grande opportunità»
ilmessaggero.it

L'intelligenza artificiale parla anche reatino. [...] dieci anni fa, in tempi ancora non sospetti c'era già chi, come Alessandro Acciai, aveva scelto di dedicare la propria vita allo studio delle architetture che emulano le reti neurali umane. [...] Trentasei anni e un curriculum che, dalla facoltà di Lettere e Filosofia di Roma Tre lo ha spinto verso la laurea magistrale in Scienze cognitive, fino alla Scuola internazionale superiore di studi avanzati di Trieste e alla Scuola di specializzazione del Cnr di Roma.

Leggi l'articolo qui.

«Non dobbiamo aver paura dell'intelligenza artificiale»
Il Messaggero

L'intelligenza artificiale parla anche reatino. [...] dieci anni fa, in tempi ancora non sospetti c'era già chi, come Alessandro Acciai, aveva scelto di dedicare la propria vita allo studio delle architetture che emulano le reti neurali umane. [...] Trentasei anni e un curriculum che, dalla facoltà di Lettere e Filosofia di Roma Tre lo ha spinto verso la laurea magistrale in Scienze cognitive, fino alla Scuola internazionale superiore di studi avanzati di Trieste e alla Scuola di specializzazione del Cnr di Roma.

In edicola.

Facing Harvard inhospitality, academic delegation seeks to expand dialogue on Israel
Bharat Times

Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...]  Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.

Read the article here.

Facing Harvard inhospitality, academic delegation seeks to expand dialogue on Israel
The Jerusalem Post

Facing an inhospitable environment with antisemitism and discrimination on campus, Harvard University academics have sought to engage in dialogue and discourse in Israel by joining a delegation of professors from six universities last Sunday. [...]  Together they worked with Israel Destination to organize a delegation of 31 academics from Harvard, Stanford, Dartmouth, the Italian International School for Advanced Studies, and the University Kore of Enna.

Read the article here.

Arte e scienza al servizio della zona umida Schiavetti
Il Piccolo (ed. Gorizia)

Si sono da poco conclusi tre workshop che hanno visto protagonisti gli allievi e le allieve di alcune classi dell'Isis Brignoli Einaudi Marconi di Staranzano e Gradisca, coadiuvati dai docenti, che hanno lavorato assieme a scienziati, videomaker, artisti, ricercatori e comunicatori scientifici, esplorando una zona affascinante e ancora poco conosciuta: il biotopo Schiavetti. [...] Curatore dei progetti Francesco Scarel, ricercatore, divulgatore e docente di comunicazione scientifica al Master della Sissa.

In edicola.